Boric Acid

Boric Acid

SCHEMBL461466

CCCCCOC(C)(C)C(C)(C)O.OB(O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.36
CA1 P00915 9/20 0.33
CA2 P00918 9/20 0.33
CA9 Q16790 9/20 0.33
CA12 O43570 4/20 0.33
MEN1 O00255 1/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33
LPAR3 Q9UBY5 6/20 0.32
LPAR2 Q9HBW0 5/20 0.32
LPAR1 Q92633 2/20 0.32
CA3 P07451 2/20 0.32
CA4 P22748 2/20 0.32
CA6 P23280 2/20 0.32
CA5A P35218 2/20 0.32
CA7 P43166 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA5B Q9Y2D0 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Boric Acid SCHEMBL28283423 0.98 CES1 (0.39) CES1CA1CA2CA9CA12
Boric Acid SCHEMBL28142311 0.98 CES1 (0.39) CES1CA1CA2CA9CA12
Boric Acid SCHEMBL28283412 0.98 CES1 (0.39) CES1CA1CA2CA9CA12
Boric Acid SCHEMBL29150377 0.98 CES1 (0.39) CES1CA1CA2CA9CA12
Boric Acid SCHEMBL28283434 0.98 CES1 (0.39) CES1CA1CA2CA9CA12
Boric Acid SCHEMBL28543765 0.98 CES1 (0.39) CES1CA1CA2CA9CA12
Boric Acid SCHEMBL28993167 0.94 TSHR (0.33) CA1CA2
SCHEMBL16465846 0.94 CES1 (0.39) CES1CA1CA2CA9CA12
SCHEMBL29219352 0.91 CES1 (0.42) CES1CA1CA2CA9CA12
SCHEMBL9940082 0.91 CES1 (0.38) CES1CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813890-A Method for synthesizing conjugated polymer by using Suzuki-Miyaura catalytic polymerization system and application thereof 中国科学院大学 2023-09-29 CN claimed
CN-117924258-A Pyridone compound derivative and application thereof 复旦大学 2024-04-26 CN disclosed
CN-112313208-B Bicyclic carboxamides and methods of use thereof 泰普斯特医疗公司 2024-04-19 CN disclosed
CN-117820094-A Method for coupling organic boron and electrophile with participation of ferric chloride 吉林大学 2024-04-05 CN disclosed
CN-117417373-A Ionic difluoromethyl copper (I) complex, synthesis method and application thereof 中国科学院上海有机化学研究所 2024-01-19 CN disclosed
CN-117157286-A Pyridyl-substituted oxo-isoindoline compounds 百时美施贵宝公司 2023-12-01 CN disclosed
CN-116813890-A Method for synthesizing conjugated polymer by using Suzuki-Miyaura catalytic polymerization system and application thereof 中国科学院大学 2023-09-29 CN disclosed
CN-116813890-A Method for synthesizing conjugated polymer by using Suzuki-Miyaura catalytic polymerization system and application thereof 中国科学院大学 2023-09-29 CN disclosed
CN-116283768-A Preparation method of aryl acridine compound 西安凯翔生物医药科技有限公司 2023-06-23 CN disclosed
CN-116253755-A Synthesis method of diaryl borate compound 湖南大学 2023-06-13 CN disclosed
CN-113527275-A SKLB1039 compound and preparation method and application thereof 成都师范学院 2021-10-22 CN disclosed
US-20160168151-A1 PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-06-16 US disclosed
US-20150031881-A1 PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-01-29 US disclosed
CN-102648174-A Novel arylated camphenes, process for their preparation and their use YISSUM RES DEV CO (IL) 2012-08-22 CN disclosed
US-20120065154-A1 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-03-15 US disclosed
US-20090181988-A1 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-07-16 US disclosed
US-7429596-B2 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-09-30 US disclosed
CN-101018552-A Intracellular receptor modulator compounds and methods LIGAND PHARM INC (US) 2007-08-15 CN disclosed
US-20050085472-A1 Pyrazolo pyrimidine derivatives and methods of use thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-04-21 US disclosed
WO-2005007085-A2 PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085472-A1 Pyrazolo pyrimidine derivatives and methods of use thereof DPYD, DHODH, DLD CES1 997/4885CA1 4544/4885CA2 4344/4885
US-20160168151-A1 PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF DPYD, DHODH, DLD CES1 997/4885CA1 4544/4885CA2 4344/4885
US-20150031881-A1 PYRAZOLO PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF DPYD, DHODH, DLD CES1 997/4885CA1 4544/4885CA2 4344/4885
US-20090181988-A1 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof DPYD, DHODH, DLD CES1 997/4885CA1 4544/4885CA2 4344/4885
US-20120065154-A1 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof DPYD, DHODH, DLD CES1 997/4885CA1 4544/4885CA2 4344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.